Last reviewed · How we verify
A Multi-Center, Randomized, Parallel-Group, Double-Blind, Efficacy and Safety Study of INS37217 Nasal Spray Versus Placebo in Subjects With Perennial Allergic Rhinitis
The purpose of this study was to determine the efficacy and safety of the study drug compared to placebo for the treatment of subjects with perennial allergic rhinitis.
Details
| Lead sponsor | Merck Sharp & Dohme LLC |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 630 |
| Start date | 2002-12 |
| Completion | 2003-04 |
Conditions
- Perennial Allergic Rhinitis
Interventions
- INS37217 Nasal Spray
Primary outcomes
- total nasal symptom score